<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p151" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_151{left:411px;top:233px;letter-spacing:-0.1px;}
#t2_151{left:411px;top:78px;letter-spacing:-0.3px;}
#t3_151{left:412px;top:630px;letter-spacing:-0.8px;}
#t4_151{left:65px;top:40px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t5_151{left:74px;top:58px;letter-spacing:-0.8px;word-spacing:-0.5px;}
#t6_151{left:82px;top:75px;letter-spacing:-1px;word-spacing:-1px;}
#t7_151{left:82px;top:90px;letter-spacing:-1px;word-spacing:-0.2px;}
#t8_151{left:74px;top:125px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#t9_151{left:82px;top:143px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#ta_151{left:82px;top:160px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#tb_151{left:82px;top:178px;letter-spacing:-1px;}
#tc_151{left:89px;top:178px;letter-spacing:-1px;word-spacing:-1.1px;}
#td_151{left:89px;top:193px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#te_151{left:82px;top:210px;letter-spacing:-1px;}
#tf_151{left:89px;top:210px;letter-spacing:-1px;word-spacing:3.2px;}
#tg_151{left:89px;top:226px;letter-spacing:-1px;}
#th_151{left:82px;top:243px;letter-spacing:-1px;}
#ti_151{left:89px;top:243px;letter-spacing:-1px;word-spacing:-0.1px;}
#tj_151{left:205px;top:243px;letter-spacing:-1px;}
#tk_151{left:82px;top:260px;letter-spacing:-1px;}
#tl_151{left:89px;top:260px;letter-spacing:-1px;word-spacing:4.8px;}
#tm_151{left:89px;top:276px;letter-spacing:-1px;}
#tn_151{left:65px;top:306px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#to_151{left:65px;top:324px;letter-spacing:-1px;word-spacing:2.4px;}
#tp_151{left:65px;top:339px;letter-spacing:-0.9px;word-spacing:-0.4px;}
#tq_151{left:65px;top:374px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#tr_151{left:65px;top:391px;letter-spacing:-1px;word-spacing:-1.5px;}
#ts_151{left:65px;top:406px;letter-spacing:-1px;word-spacing:-0.1px;}
#tt_151{left:65px;top:424px;letter-spacing:-0.9px;}
#tu_151{left:65px;top:441px;letter-spacing:-1px;word-spacing:6.3px;}
#tv_151{left:65px;top:457px;letter-spacing:-1px;word-spacing:-0.1px;}
#tw_151{left:65px;top:474px;letter-spacing:-1px;word-spacing:-0.1px;}
#tx_151{left:65px;top:509px;letter-spacing:-1px;word-spacing:-0.3px;}
#ty_151{left:74px;top:526px;letter-spacing:-1px;}
#tz_151{left:80px;top:526px;letter-spacing:-1px;word-spacing:3.6px;}
#t10_151{left:80px;top:542px;letter-spacing:-1px;word-spacing:1.3px;}
#t11_151{left:80px;top:557px;letter-spacing:-1px;word-spacing:-0.8px;}
#t12_151{left:80px;top:572px;letter-spacing:-1px;word-spacing:6.9px;}
#t13_151{left:80px;top:587px;letter-spacing:-0.9px;word-spacing:-0.1px;}

.s1_151{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_151{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_151{
	FONT-SIZE: 37.6px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_151{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.s5_151{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.t.m0_151{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts151" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg151Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg151" style="-webkit-user-select: none;"><object width="433" height="649" data="151/151.svg" type="image/svg+xml" id="pdf151" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_151" class="t m0_151 s1_151">O Guia do Jovem Internista </div>
<div id="t2_151" class="t m0_151 s2_151">2016</div>
<div id="t3_151" class="t s3_151">149</div>
<div id="t4_151" class="t s4_151">• Profilaxia</div>
<div id="t5_151" class="t s4_151">- Primária </div>
<div id="t6_151" class="t s5_151">CD4+ &lt;100 cells/μL e IgG positiva; continuar até após 3 meses com </div>
<div id="t7_151" class="t s5_151">CD4 &gt;200 cells/μL</div>
<div id="t8_151" class="t s4_151">- Esquemas:</div>
<div id="t9_151" class="t s5_151">- SMX+TMP 800mg + 160mg q12h</div>
<div id="ta_151" class="t s5_151">- Alternativas: </div>
<div id="tb_151" class="t s5_151">- </div>
<div id="tc_151" class="t s5_151">Dapsona 50mg 1xdia+ Pirimetamina 50mg 1 x semana + Ac.fólico </div>
<div id="td_151" class="t s5_151">25mg 1 x semana</div>
<div id="te_151" class="t s5_151">- </div>
<div id="tf_151" class="t s5_151">Dapsona 200mg + Pirimetamina 75mg + Ac.fólico 25mg - 1xse-</div>
<div id="tg_151" class="t s5_151">mana</div>
<div id="th_151" class="t s5_151">- </div>
<div id="ti_151" class="t s5_151">Atovaquona 1500mg po </div>
<div id="tj_151" class="t s5_151">1xdia</div>
<div id="tk_151" class="t s5_151">- </div>
<div id="tl_151" class="t s5_151">Atovaquona 1500mg + Pirimetamine 25mg + Leucovirina 10mg </div>
<div id="tm_151" class="t s5_151">1xdia</div>
<div id="tn_151" class="t s4_151">- Secundária: </div>
<div id="to_151" class="t s5_151">Após tratamento de toxoplasmose cerebral; até após 6 meses de CD4 </div>
<div id="tp_151" class="t s5_151">&gt; 200 cells/μL</div>
<div id="tq_151" class="t s4_151">- Esquemas:</div>
<div id="tr_151" class="t s5_151">Sulfadiazina 500-1000mg po 1xdia + Pirimetamina 25-50mg po 1xdia + </div>
<div id="ts_151" class="t s5_151">Ac.fólico 10-25mg po 1xdia</div>
<div id="tt_151" class="t s5_151">Alternativas: </div>
<div id="tu_151" class="t s5_151">Clindamicina 300-450mg po 6/6 - 8/8h + Pirimetamina 25-50mg po </div>
<div id="tv_151" class="t s5_151">1xdia + Ac.fólico 10-25mg po 1xdia (não previne PPJ)</div>
<div id="tw_151" class="t s5_151">Atovaquona 750mg po 6/6 - 12/12h</div>
<div id="tx_151" class="t s4_151">• Micobacterium Tuberculosis</div>
<div id="ty_151" class="t s5_151">• </div>
<div id="tz_151" class="t s5_151">Manifestações clínicas: varia de acordo com o estádio de infecção </div>
<div id="t10_151" class="t s5_151">pelo VIH. Nos casos de imunidade preservada - doença cavitária tí-</div>
<div id="t11_151" class="t s5_151">pica do lobo superior. Na fase de imunodeficiência grave- infiltrados </div>
<div id="t12_151" class="t s5_151">intersticiais, miliar, pouca ou nenhuma cavitação e linfadenopatia </div>
<div id="t13_151" class="t s5_151">intratorácica, formas extrapulmonares. </div>

<!-- End text definitions -->


</div>
</body>
</html>
